drugset / Trial / NCT04773977
Clinical Study of IBI362 in Healthy Chinese Male Subjects
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a study to evaluate the pharmacokinetic characteristics and safety of IBI362 lyophilized powder and IBI362 liquid formulation in healthy Chinese male subjects.
Timeline
- Start
- 2021-03-03
- Primary completion
- 2021-03-09
- Completion
- 2021-06-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mazdutide | Protein / enzyme biologic | — | Subcutaneous |